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N-Acetyl-leukotriene E4 administered to conscious freely moving rats produced a dose-dependent vasoconstriction 
in the mesenteric vessels which led to profound reduction of blood flow to the gut. Renal and hindquarter blood flow 
and vascular resistance were not affected even by high doses of N-acetyl-leukotriene E4 . N-Acetyl-leukotriene E4 was 
10-fold more potent than the thromboxane analog U-46619 and 1000-fold more potent than prostaglandin F2a but 
2-5-fold less potent than leukotriene D4/E4 to induce mesenteric vasoconstriction. These data indicatc that N-acetyl-
leukotriene E4 is a biologically active metabolite of peptide leukotrienes, and might play a roJe in cardiovascular 
derangements mediated by leukotrienes. 
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1. Introduction 
N-Acetyl-leukotriene (N-Ac-leukotriene) E4 is 
a recently discovered metabolite of the cysteinyl 
leukotrienes, leukotriene C4 , D4 and E4 (Denz-
linger et al., 1985). Although this leukotriene 
metabolite has been discovered so far only in the 
bile of some species (e.g. rat), an enterohepatic 
cycle for leukotriene has already been demon-
strated (Denzlinger et al., 1986) which provides a 
route for leukotriene metabolites such as N-Ac-
leukotriene E4 access to the systemic circulation. 
The biological significance of such a cycle would 
however depend on the degree of the biological 
activities preserved in the leukotriene metabolites. 
We have previously reported that leukotrienes 
have profound vasoconstrictor effect on selected 
peripheral blood vessels of the rat, especially on 
the coronary (Zukowska-Grojec et al., 1985) and 
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the mesenteric (Eimer) et al., 1986) circulation. 
Therefore, we have postulated that if N-Ac-
leukotriene E4 would have any appreciable vascu-
lar activity in the rat it would be apparent in the 
mesenteric circulation. 
This hypothesis was tested in the conscious rat 
in which Doppler flow probes were implanted on 
the renal and superior mesen teric vessels as well as 
on the lower abdominal aorta for hindquarter 
blood flow measurement. Using this technique is 
the only way to obtain on line, continuous mea-
surements of blood flow changes in the conscious 
rat for substances which produce instant and short 
Iasting responses. 
2. Materials and methods 
2.1. Anima/ preparation 
The rats were anesthetized with an intramuscu-
lar injection of ketamine (130 mg/kg) and 
acepromazine (1.3 mgjkg). Miniaturized Doppler 
flow probes (Valpey-Fisher, MA) were implanted 
0014-2999/88/$03.50 © 1988 Elsevier Science Publishers B.V. (Biomedical Division) 
332 
to measure hindquarter blood flow, renal blood 
flow and superior mesenteric blood flow according 
to the method of Haywood et al. (1981). Twenty-
four hours before the experiment, polyethylene 
catheters (PE50) were inserted into the femoral 
vessels as described earlier (Eimerl et al., 1986). 
Seven days after the flow probe implantation 
the rat was connected to the flow probe connec-
tors and the arterial line was connected to a 
pressure transducer (Narco RP1500i). The blood 
pressure (mean, systolic, diastolic) and heart rate 
continuously recorded on the computerized Nar-
cotrace 80 physiograph. The regional blood flow 
was measured with a pulsed Doppler flowmeter 
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545c-3) and the blood flow recordings continu-
ously monitored on the Narcotrace 80 physio-
graph. Vascular resistance was calculated by divid-
ing the mean arterial pressure by blood velocity 
(Doppler shift in kilohertz). Changes in blood 
flow and vascular resistance are expressed as a 
percent of control values. 
2.2. Drugs 
Pure synthetic cysteinyl leukotrienes were pro-
vided by Merck-Frosst, Canada. Prostaglandin F2a 
was purchased from Sigma and the stable throm-
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Fig. 1. Effect of N-Ac-leukotriene E4 on hemodynamic variables in the conscious rat. Saline (25 111/100 g) or increasing doses of 
N-Ac-Jeukotriene E4 were injected i.v. at 20 rnin intervals. Values indicate mean ± S.E.M. N = numher of animals. MAP = mean 
arterial pressure, HR = heart rate, bpm = beats per min, BF = blood flow, VR = vascular resistance, S = saline. Asterisks indicate 
statistical significance from S by Student-Newman-Keuls test. 
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Fig. 2. Log-dose relationship of the mesenteric vasoconstrictor patendes of various leukotrienes, thromboxane analog U-46619 and 
prostaglandin F2a in the conscious rat. lncreasing doses of leukotrienes, U-46619 and prostaglandin F2 a were injected i.v. at 20 min 
intervals. %.1MVR = percent change in mesenteric vascular resistance. N = number of animals, r = correlation coefficient, p = 
probability. 
boxane analog U-46619 (9,11-dideoxy-9a,l1a-
methanoepoxy-prostaglandin F2a) from Cayman 
Chemical. The leukotrienes and prostaglandins 
were stored at - 80 ° C and thawed only once 
prior to administration in 200 p.l of sterile 0.9% 
N aCl. Saline, leukotrienes and prostaglandins were 
injected i.v. in a volume of 25 1-Ll/100 g body 
weight. 
2.3. Statistics 
All data in text and figures are mean values ± 
S.E. for the indicated number of rats. ANOVA 
followed by the Student-Newman-Keuls test for 
multiple range comparisons was used along with 
linear regression analysis of the peak responses of 
the various leukotrienes. 
3. Results 
N -Ac-leukotriene E4 produced only a slight 
increase in the mean arterial pressure (5-10 mm 
Hg) and no consistant change in heart rate, renal 
blood flow or renal vascular resistance up to the 
highest dose used (fig. 1). However, a dose-depen-
dent vasoconstriction was demonstrated in the 
mesenteric circulation which reached a maximum 
of + 323 ±55% at the highest dose. When N-Ac-
leukotriene E 4 is compared to leukotriene 0 4 , 
leukotriene E 4 thromboxane analog U-46619 and 
prostaglandin F2a (fig. 2) it is 2.1- and 5-fold less 
potent than leukotriene E4 and leukotriene 0 4 in 
doubling mesenteric vascular resistance, respec-
tively. N-Ac-leukotriene E 4 is however, approxi-
mate 10-fold more potent than U-46619 and 
1000-fold more potent then prostagtandin F2 a in 
its capacity to constrict the mesenteric circulation. 
Also, if the time for blood flow recovery is consid-
ered, the area score of N-Ac-leukotriene E4 effect 
at 10 p.gjkg is 7.6 ± 0.9 Hz· s while that of the 
same dose of leukotriene 0 4 is 4.9 ± 0.8 Hz· s 
(P < 0.05, n = 6). All the eicosanoids were, how-
ever, far less potent than vasopressin which at 
doses of 0.03-0.1 p.gjkg induced a strong increase 
in mesenteric vascular resistance with peak re-
sponses of + 1145 ± 859 and +2177 ± 1164%, re-
spectively. 
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The hindquarter blood flow showed a slight but 
significant (up to 30%) increase after N-Ac-
leukotriene E4 administration but the increase in 
hindquarter blood flow was primarily due to the 
small increase in mean arterial pressure since 
hindquarter vascular resistance tended to decrease 
although not significantly (fig. 1). High doses (30-
100 JLg/kg) of U-46619 induced pressure and re-
nal vasoconstrictor responses but had no effect on 
hindquarter blood flow. Prostagtandin F2a at the 
highest dose (100 1-'g/kg) increased hindquarter 
blood flow ( + 93 ± 19%) and decreased 
hindquarter vascular resistance (- 42 ± 10% ). This 
dose of prostaglandin F2a also decreased renal 
blood flow (- 32 ± 6%) with no significant effect 
on renal vascular resistance. It also first decreased 
( - 31 ± 3 mm Hg) and then increased ( + 26 ± 3 
mm Hg) mean arterial pressure. 
4. Discussion 
The data presented in this report clearly 
demonstrates that N-Ac-leukotriene E 4 is a bio-
logically active metabolite of the peptide-
leukotrienes. The potency of N-Ac-leukotriene E4 
(measured as peak response) was 2- and 5-fold less 
active than leukotriene E4 and D4 respectively but 
due to a somewhat prolonged action the overall 
activity of N-Ac-leukotriene E4 in the mesenteric 
circulation is comparable to that of leukotriene 
D4 . However, N-Ac-leukotriene E4 showed no 
constrictive activity in the hindquarter or renal 
circulation while leukotriene D4 is clearly active in 
constricting these blood vessels at I/10th of the 
maximal dose of N-Ac-leukotriene E4 used in this 
study (Eimerl et al., 1986). This difference be-
tween leukotriene D4 and N-Ac-leukotriene E4 
might point towards some variance in leukotriene-
receptors in different blood vessels even in the 
same species. 
The effects of N-Ac-leukotriene E4 shown in 
our study differ from those described in the pig 
(Foster et al., 1986). In the latter species N-Ac-
leukotriene E4 was found to be virtually inactive 
in modifying cardiovascular and respiratory 
parameters. However, N-Ac-leukotriene E 4 is not 
formed in the pig (Ezra et al., 1987) and therefore 
the biological actions of N-Ac-leukotriene E4 in 
the pig are anyway of little biological significance. 
In the rat, where N-Ac-leukotriene E4 is a major 
leukotriene metabolite (Denzlinger et al., 1985) 
re-entering to the plasma of this biologically active 
metabolite could account for the prolonged 
mesenteric vasoconstriction associated with acute 
systemic anaphylaxis in this species (Zukowska-
Grojec and Feuerstein, 1985). Furthermore, one 
cannot exclude the possibility of additional forma-
tion of N-Ac-leukotriene E4 in the plasma from 
leukotriene E4 absorbed from the bile. This possi-
bility however awaits further clarification. 
The data presented in this report also raise the 
question of which of the leukotriene metabolites is 
a non active end product. Recent sturlies point to 
the formation of several w-oxidation products of 
leukotriene E4 but further sturlies would be neces-
sary to examine their biological activities. 
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